Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2023 May 8;72(8):2873. doi: 10.1007/s00262-023-03455-x

Correction to: Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis

Guanfang Liu 1,2, Qi Zhang 1, Jingying Yang 1,3, Xiaomin Li 1, Luhua Xian 4, Wenmin Li 4, Ting Lin 4, Juan Cheng 1, Qiwen Lin 5, Xiuzhang Xu 5, Qin Li 6, Yu Lin 7, Maohua Zhou 4,, Erxia Shen 1,
PMCID: PMC10991637  PMID: 37154852

Correction to: Cancer Immunology, Immunotherapy (2022) 71:277–287 10.1007/s00262-021-02978-5

The original version of this article unfortunately contained a mistake in the acknowledgements section. Acknowledgements section should read as.

Acknowledgements This work was supported by the National Natural Science Foundation of China (81971482, to ES), the Science and Technology Program of Guangzhou (No.202102080341 to ES), and the Science and Technology Planned Project of Bureau of Education of Guangzhou (No. 1201610221, to ES).

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Maohua Zhou, Email: zmhuagz@126.com.

Erxia Shen, Email: erxia_shen@gzhmu.edu.cn.


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES